US-Sweden Cancer Summit - Bridging the Research to Implementation Gap
W. Kimryn Rathmell, M.D., Ph.D., NCI Director Ms. Andrea Palm, HHS Deputyn Director Ms. Acko Ankarberg Johansson, Minister for Healthcare, Sweden Catharine Young, Ph.D. Assistant Director, White House Cancer Moonshot Engagement and Policy Urban Ahlin, Ambassador of Sweden
On March 13, 2024, the United States and Sweden signed an Implementing Arrangement on Cancer under the Bilateral Agreement on Cooperation in Science and Technology. This renewed agreement was signed by the Deputy Secretary of the U.S. Department of Health and Human Services, Ms. Andrea Palm and Sweden's Minister for Health Care, Ms. Acko Ankarberg Johannson.
Following the signing, was the US-Sweden Cancer Summit where participants explored the latest advances in cancer research and implementation science. The Summit united policymakers, experts, researchers, and advocates from both nations. In addition, participants discussed furthering inclusion and precision in cancer prevention, detection, treatment, and care, as well as, opportunities for funding bilateral collaboration. NCI and other USG experts joined Swedish colleagues to present at the Summit including :
- Dr. W. Kimryn Rathmell, Director, National Cancer Institute
- Catharine Young, Assistant Director, White House Cancer Moonshot Engagement and Policy, US
- Dr. Satish Gopal, Director, Center for Global Health, National Cancer Institute
- Dr. Henry Rodriguez, Director, Office of Cancer Clinical Proteomics Research, National Cancer Institute
- Dr. Lori Minasian, Deputy Director, Division of Cancer Prevention, National Cancer Institute
- Dr. David Chambers, Deputy Director, Implementation Science, National Cancer Institute
This renewed collaboration strengthens our commitment to advance global cancer research to benefit all people worldwide.